المؤلفون: Aburisheh K; University Diabetes Center, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia., AlKheraiji MF; University Diabetes Center, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia., Alwalan SI; University Diabetes Center, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia., Isnani AC; Obesity Research Center, College of Medicine, King Saud University, P.O. Box 2925, Riyadh, 11461, Saudi Arabia., Rafiullah M; Strategic Center for Diabetes Research, College of Medicine, King Saud University, Riyadh, Saudi Arabia., Mujammami M; University Diabetes Center, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.; Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia., Alfadda AA; Obesity Research Center, College of Medicine, King Saud University, P.O. Box 2925, Riyadh, 11461, Saudi Arabia. aalfadda@ksu.edu.sa.; Strategic Center for Diabetes Research, College of Medicine, King Saud University, Riyadh, Saudi Arabia. aalfadda@ksu.edu.sa.; Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia. aalfadda@ksu.edu.sa.

المصدر: BMC endocrine disorders [BMC Endocr Disord] 2023 Mar 01; Vol. 23 (1), pp. 50. Date of Electronic Publication: 2023 Mar 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101088676 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6823 (Electronic) Linking ISSN: 14726823 NLM ISO Abbreviation: BMC Endocr Disord Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2* , Diabetic Nephropathies* , Hypertension*, Humans ; Aged ; Prevalence ; Cholesterol, LDL ; Cross-Sectional Studies ; Retrospective Studies ; Sodium Potassium Chloride Symporter Inhibitors ; Risk Factors